| Acquired by | Endologix |
| Date | 10/10 |
| Terms | Cash and Stock |
| Website | nellix.com |
| Phone | 650-213-8700 |
| Employees |
| Series C, 3/08 Essex Woodlands Health Ventures Incept | $6.5M |
Nellix has developed an original device designed to address and expand the indication for the less invasive treatment of Abdominal Aortic Aneurysms (AAAs) and Thoratic Aortic Aneurysms (TAAs). Enabling the treatment of all aneurysms with a low profiles delivery system and innovative endograft, the Nellix device has the potential to double the market size for Endovascular Aneurysms Repair (EVAR), which exceeded $800M in 2008 with a 16% CAGR (Med Tech Insight).
